Stifel Sees 4 Reasons to add to Boston Scientific (BSX) Positions on Weakness

October 16, 2020 7:34 AM EDT Send to a Friend
Stifel analyst Rick Wise reiterated a Buy rating and $47.00 price target on Boston Scientific (NYSE: BSX) after shares have ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login